Ambient Air Pollution Health Impacts in High‐Income Countries, Part II: A Case Study in the United Arab Emirates
Risk Analysis · 2026-11 · 46 (11)
DOI: 10.1111/risa.70368 ↗Kurz gefasst
Fachartikel in der Zeitschrift Risk Analysis, online erschienen am 14.10.2026. Verfasst von Tongchuan Wei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Civil, Construction, and Environmental Engineering, North Carolina State University, Raleigh, North Carolina, USA. Hauptthemen laut MEDLINE: Air Pollution. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Abu Dhabi Public Health Center.
Abstract (Originalsprache)
Ambient air pollution poses major global public health risks, particularly in rapidly developing regions, including the Arabian Gulf. This study estimates the disease burden attributable to anthropogenic air pollution (particulate matter [PM] and ozone) in Abu Dhabi, United Arab Emirates, for 2019–2022 and compares findings to previous estimates for 2008. Burdens were calculated using updated air quality, population, and health incidence data for 2019–2022 along with concentration–response functions from recent epidemiologic evidence. Results show that Abu Dhabi's investments in air quality management have paid off in preventing air quality from deteriorating as much as would be expected given the doubling of the population between 2008 and 2022. However, epidemiologic evidence gathered during this period indicates that PM exposure has stronger negative effects on mortality risks than previously thought. As a result, estimated deaths attributable to anthropogenic ambient air pollution increased between 2008 and 2022, from 231 (90% uncertainty interval [UI]: 59–427) to 1249 (90% UI: 507–2169). Total hospital visits attributable to PM and ozone exposure also increased. These increases reflect combined effects of population growth, higher pollutant exposures, improved medical record‐keeping, and updated evidence on health risks. Urban centers, with higher pollutant concentrations and population densities, experience the highest risks, highlighting the need for targeted interventions to address air pollution hotspots. This work provides policymakers with up‐to‐date insights on the health impacts of ambient air pollution and underscores the importance of continued investments in air quality management in Abu Dhabi.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Civil, Construction, and Environmental Engineering, North Carolina State University, Raleigh, North Carolina, USA.
- Research Triangle Institute (RTI) International, Research Triangle Park, North Carolina, USA.
- Abu Dhabi Public Health Center, Abu Dhabi, UAE.
- Department of Public Health and Epidemiology, College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, UAE.
- School of Population Health, Faculty of Medicine, University of New South Wales, Sydney, Australia.
ORCID-Profile: Tongchuan Wei, Nick Kruskamp, Jacqueline MacDonald Gibson
Förderung
- Abu Dhabi Public Health Center
Zitieren
APA
Wei, T., Ellermeier, N., Kruskamp, N., Madhi, A. M., Shamsi, L. J. A., Saddik, B. A., & Gibson, J. M. (2026). Ambient Air Pollution Health Impacts in High‐Income Countries, Part II: A Case Study in the United Arab Emirates. Risk Analysis, 46(11). https://doi.org/10.1111/risa.70368
Vancouver
Wei T, Ellermeier N, Kruskamp N, Madhi AM, Shamsi LJA, Saddik BA, et al. Ambient Air Pollution Health Impacts in High‐Income Countries, Part II: A Case Study in the United Arab Emirates. Risk Analysis. 2026;46(11). doi:10.1111/risa.70368
BibTeX
@article{Wei2026,
author = {Wei, Tongchuan and Ellermeier, Nathan and Kruskamp, Nick and Madhi, Amal Mubarak and Shamsi, Latifa Juma Al and Saddik, Basema Ahmad and Gibson, Jacqueline MacDonald},
title = {Ambient Air Pollution Health Impacts in High‐Income Countries, Part II: A Case Study in the United Arab Emirates},
journal = {Risk Analysis},
year = {2026},
volume = {46},
number = {11},
doi = {10.1111/risa.70368}
}
EUVIMED